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Congenital pineoblastoma and parameningeal
rhabdomyosarcoma: concurrent two embryonal
tumors in a young infant
Abstract Background: Pineoblasto-
mas are very rare brain tumors in fetus
and neonates, comprising only 0.9%
of congenital brain tumors. The
occurrence of multiple tumors of
different histopathologic types in the
same individual is a rare event, most
often encountered in hereditary cancer
syndromes. Case report: We report a
female fetus presented with a con-
genital pineoblastoma at the 32nd
week of gestation, with hydrocepha-
lus and concurrent parameningeal
embryonal rhabdomyosarcoma in
early infancy. Results: Cytogenetic
analysis showed normal karyotype in
the peripheral blood of the patient,
and p53 mutational analysis revealed
no germ line mutations. Discussion:
This is the first case with concurrent
congenital pineoblastoma and para-
meningeal embryonal rhabdomyosar-
coma in early infancy. We suggest
that concurrence of these tumors
could be due to mutations in other
tumor suppressor genes or secondary
to exposure to unknown in utero
factors.
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Introduction
Congenital neoplasms represent 2.5% of all tumors in
pediatric age [1, 2]. Although congenital intracranial
tumors only account for 0.5–1.5% of all childhood brain
tumors, they are responsible for 5–20% of the deaths due to
neoplasms in this age group [2–4]. Pineoblastomas are un-
common brain tumors in the fetus and neonates, compris-
ing only 0.9% of congenital brain tumors [4, 5]. The
occurrence of multiple tumors of different histopathologic
types in the same individual is even more rare, most often
seen in hereditary cancer syndromes. In these syndromes,
increased cancer susceptibility results from germ line
mutations in various genes controlling the cell growth [6].
We present a case with concurrent congenital pineoblas-
toma and parameningeal embryonal rhabdomyosarcoma in
early infancy. Mutations of a well-defined tumor suppres-
sor gene, p53, is studied in the peripheral blood cells of the
patient.
Case report
A 28-year-old woman at the 32nd week of gestation was
referred to the Division of Pediatric Neurosurgery at
Marmara University Medical Center due to dilated third
and lateral ventricles and a hyperechoic lesion in the pineal
area detected by fetal ultrasonography (Fig. 1a). The ul-
trasonography revealed no extracranial abnormalities, and
medical history of the mother including pregnancy was
uneventful. A fetal MRI was performed on the 33rd week of
gestation, which showed a mass lesion 2×1×1 cm in the
pineal gland region causing hydrocephalus (Fig. 1b). Family
history was negative for malignancies, and there were no
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predisposing hereditary disorders related to brain tumors. No
in utero exposure to environmental risk factors could be
identified from the history. Due to progressive increase in
ventricule dimensions, at the 35th week of gestation, the
mother underwent cesarean section. The female newborn
was in good condition and had a birth weight of 2,800 g.
There was no congenital anomalies, and physical examina-
tion was normal, except for macrocephaly and wide bulging
fontanels and dilated scalp veins. On the MRI of the first
postnatal day, the size of the pineal gland mass was increased
to 3.5×1.5×2 cm, as well as the ventricular size (Fig. 2a). On
the postnatal first day, a ventriculoperitoneal shunt was
installed to relieve the increased intracranial pressure and
wait for clinical stability. Alpha fetoprotein levels of cere-
brospinal fluid and serum obtained during the operation were
3,199 and 91,000 IU/ml, respectively. The general condition
of the baby was quite well. Although hydrocephalus was
decompressed, on postnatal 45th day, MRI revealed pro-
minent progression of the mass lesion (Fig. 2b). On the
postnatal 47th day, radical surgery was performed using the
right occipital transtentorial approach. A mass with cystic
and solid components was seen at the location of the pineal
region. The mass was adherent to both the internal cerebral
veins and the vein of Galen. The mass was also extending
into the posterior fossa, compressing the cerebellum with an
ependymal infiltration. After aspiration of xanthochromic
cyst fluid, the fragile solid portion of the tumor was
completely removed with the help of ultrasonic aspirator.
The postoperative period was uneventful. MRI on the
postoperative first day and postnatal 30th day showed no
evidence of residual mass (Fig. 2c). The MRI of the
postoperative tenth day presented normal-sized ventricles
(Fig. 2d). Cerebrospinal fluid cytologic examination and
whole-spinal MRI revealed no drop metastasis or meningeal
dissemination. Histopathologically, excised tumoral mass
showed a diffuse, infiltrative, cellular tumor composed of
small round cells with hyperchromatic nuclei and scant
amphophilic cytoplasm. Tumor had cellular atypia but low
mitotic index (0–1/hpf) and lacked necrosis and vascular
endothelial proliferation. Immunohistochemically, tumor
cells were reactive for vimentin and synaptophysin. S100
and glial fibrillary acidic protein (GFAP) did not show any
immunoreactivity. MIB-1 proliferative index was 33%. The
final histopathologic diagnosis was pineoblastoma (Fig. 3).
The patient was started on The Societé Française
Oncologie Pédiatrique (SFOP) chemotherapy protocol on
the postoperative tenth day [7]. She received two courses of
chemotherapy with 21 days interval. Original regimen was:
course 1; carboplatin 15 mg/kg on day 1, procarbazine 4 mg/
kg on days 1–7 and course 2; etoposide 5 mg/kg on days 1
and 2, cisplatinum 1 mg/kg on days 1 and 2. All drugs were
used with a dose reduction schedule due to the young age of
the patient. After the second course of the chemotherapy, she
was admitted to the hospital center with fascial asymmetry. A
solid painless mass was palpated on the right maxillofascial
region. MRI showed a mass lesion originating from right
maxillary sinus, in addition to liver, lung, and vertebral
metastasis (Fig. 4a,b). An incisional biopsy of the maxillary
mass was performed at the age of 3 months, and histologic-
ally, tumor consisted of densely packed small round cells
with intervening hypocellular loose stroma. Tumor cells
were mostly hyperchromatic small round cells with occasio-
nal spindle cells and few number of cells having eosinophilic
cytoplasm. Immunohistochemically, tumor cells were diffu-
sely positive with vimentin and negative for leukocyte com-
mon antigen (LCA), cytokeratin, neuron-specific enolase
(NSE), chromogranin, and S-100. Desmin was detected in
the cells with discernible cytoplasm (Fig. 5). The pathologic
diagnosis was embryonal rhabdomyosarcoma. Cytogenetic
analysis was done from the peripheral blood lymphocyte
cultures that showed normal karyotype. The p53 gene
mutation was studied in peripheral blood cells of the patient
to identify any genetic etiology and to give genetic coun-
seling. We sequenced exons 2 thru 11 including the splice
sites to search for mutations in the genomic DNA extracted
from peripheral blood cells of the patient. The primer
sequences were: ex2F (ccagggttggaagtgtctcat), ex3R (gag
cagtcagaggaccaggtc), ex4F (gacctggtcctctgactgct), ex4R
(gccaggcattgaagtctcat), ex5F (acttgtgccctgactttcaact), ex6R
(gccactgacaaccaccctta), ex7F (cctcatcttgggcctgtgtt), ex7R
(tggaagaaatcggtaagaggtg), ex8F (ggagtagatggagcctggttt),
ex9R (aagaaaacggcattttgagtg), ex10F (caattgtaacttgaaccatc),
Fig. 1 Prenatal ultrasonography
and MRI. a Fetal ultrasonogra-
phy revealed dilated ventricules
and a hyperechoic lesion in the
pineal area (arrow). b Axial T2
weighted fetal MR image dem-
onstrates a cystic mass lesion
with heterogeneous signal in-
tensity in pineal region with
colpocephaly (arrow)
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Fig. 3 a Tumor composed of
small round cells infiltrating the
neural tissue (H & E, ×100). b
Diffuse strong synaptophysin
immunopositivity in tumor cells
(streptavidin–biotin, ×200). c
Diffuse strong vimentin immu-
nopositivity in tumor cells
(streptavidin–biotin ×200)
Fig. 2 a T1 weighted contrast
image shows that the pineal
mass was enlarged and reached
approximately 3×1.5×2 cm di-
mensions (arrow). The cystic
components of the lesion are
better demonstrated, and hydro-
cephalus is more prominent. b
On postnatal 45th day, axial T1
weighted MR image after i.v.
contrast shows decrease in ven-
tricular size due to shunt place-
ment. Further enlargement of
the pineal mass is seen (arrow).
c and d After successful surgery,
the mass lesion was removed
totally. There is no evidence of
residual tumor on early (c) and




ex10R (gggtttggatgttctgtgga), ex11F (gcacagaccctctcactc-
atgt), ex11R (tcccaaacatccctcacagt). The amplification con-
ditions were as follows: 95°C 2 min initial denaturation,
followed by 35 cycles of 94°C 1 min, 60°C 1 min, and 72°C
1 min, except exon 10, for which the annealing was 56°C.
After amplification, the PCR products were purified by
QIAquick PCR purification kit (Qiagen) and the cycle
sequencing reaction was done using the Big Dye Terminator
Cycle Sequencing Kit (Applied Biosystems). The sequen-
cing analysis was done on the Perkin Elmer-310 Genetic
Analyzer.
There was no disease-causing mutation or other
alterations, except that the patient carried the arg72 variant
at codon 72 of exon 4, as homozygous.
After informing the family about the poor prognosis of the
tumors, the parents agreed to proceed with chemotherapy to
stop progression of the maxillary mass without any further
invasive intervention. Three courses of EVAC chemotherapy
regimen were administered (etoposide 5 mg/kg on days 1
and 2, vincristine 0.05 mg/kg on day 1, actinomycin-D
15 gamma/kg on days 1–3, cyclophosphamide 60 mg/kg on
day 1; all drugs were used with a dose reduction due to the
young age of the patient). After the two courses of EVAC
chemotherapy protocol, maxillofascial mass showed clinical
regression and abdominal ultrasonography revealed com-
plete regression of liver metastases. Following the third
EVAC chemotherapy course, the patient presented with
convulsions and recurrence of pineoblastoma was seen on
cranial MRI (Fig. 6a,b). The family refused no further
chemotherapy, and the patient died at home in the following
days.
Discussion
The use of perinatal ultrasonography and fetal MRI permit
early detection of congenital brain tumors [8]. The initial
ultrasound finding in our case was ventricular dilatation
and suspicious hyperechoic lesion in the pineal region.
Fetal intracranial tumors rarely cause in utero ventricular
dilatation, with a prevalence of only 1.1% of all the patients
with in utero hydrocephalus [9, 10]. In the present case, the
hyperechoic pineal lesion in the fetal ultrasonography led
us to a fetal MRI that confirmed a tumoral etiology for the
obstructive hydrocephalus. Fetal MRI is a more accurate
imaging method in depicting the tumor and its character-
istics as well as in taking a decision with regard to man-
agement of pregnancy [8, 9]. If such a tumor is detected
before the 24th week of gestation, termination of pregnan-
cy could be discussed, while the prognosis of the fetus has
been generally poor [3]. Mortality during delivery was
reported to be 92% in infants with congenital brain tumors
[8]. Early intervention for shunting procedure and suc-
cessful total resection of the brain tumor provided a good
early neurological outcome.
Congenital central nervous system tumors are rare and
their location, histologic types, biologic behavior and
response to therapy are different from those in the older
children [2, 4]. Primary intracranial tumors are mostly
located in the supratentorial region in neonates and young
infants, in contrast to older children in whom the majority
are found within the posterior fossa [2, 11, 12].
Primitive neuroectodermal tumors (PNETs) including
pineoblastomas have been noted to have the worst prognosis,
metastasizing widely throughout the cerebrospinal fluid
pathways, invading the meninges and the spinal cord [4, 7].
Outcome is related to the size, location, surgical resectability,
and the condition of the infant at the time of diagnosis [4].
Surgical resection is an important component of the multi-
modal therapy. Due to low prevalence of pineoblastomas and
Fig. 4 a Coronal fat saturated T1 weighted MR image demonstrate
a mass lesion (arrows) on the right side originating from pterygoid
muscles, obliterating the maxillary sinus, invading the inferior wall
of the orbit, obliterating the fatty plane under inferior rectus muscle,
invading inferior and middle conchae, reaching the nasal septum,
eroding the palatum durum. The globe is displaced superiorly by the
mass effect. b Peripheral, round metastatic lung lesions are seen on
axial T1 weighted image (arrows)
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operative risks in this age group, it has been quite difficult to
determine the results of surgical removal of the congenital
brain tumors in the newborns and infants [7, 8]. In our case, a
ventriculoperitoneal shunt was inserted on the first postnatal
day and tumor could be resected without any surgical com-
plication within the neonatal period.
Although cranial and spinal radiotherapy following sur-
gery is the gold standard for the treatment of pineoblastoma,
with its severe and irreversible sequelae, it is not a rec-
ommended therapeutic option in infancy [5, 11]. Chemo-
therapy alone, at least in conventional doses, appears to be
insufficient as treatment for younger children with pine-
oblastomas, where rapid tumor progression and death is
almost unavoidable [5]. Marec-Berard et al. [7] reported 25
children under 5 years of age with supratentorial PNETs
treatedwithBB SFOPprotocol. Postoperative chemotherapy
alone maintained 29 and 14% overall survival at 2 and 5
years, respectively; relapse-free survival was 4% at 2 years
[7]. In the presented case, a chemotherapy directed to rhab-
domyosarcoma was administered following two courses of
chemotherapy administered for pineoblastoma. Cessation of
the chemotherapy directed to pineoblastoma may be the
reason for early recurrence of the brain tumor.
Although PNETs may metastasize to distant sites, such as
the lungs, liver, lymph nodes, and bone marrow, in our pa-
tient, distant metastatic lesions were most likely to originate
from rhabdomyosarcoma because primary brain tumor was
already in remission at the time, and these were common
metastatic sites for rhabdomyosarcoma. Rhabdomyosarco-
ma is the most common soft tissue sarcoma of the childhood
[13]. It is known that the risk of developing two or three
primary neoplasms is higher in patients with soft tissue sar-
coma compared with the general cancer population [14].
Multiple tumors of different histopathologic types in the
same individual is rare, generally seen in hereditary cancer
syndromes. In these syndromes, increased cancer suscepti-
bility results from germ line mutations in various genes con-
trolling cell growth [6, 13, 15]. Although there was no family
Fig. 6 a Axial image shows the
reduced dimensions of rhabdo-
myosarcoma (black arrow).
However, reoccurrence of pine-
ablastoma is seen (white arrow).
b. Sagittal T1 weighted image
demonstrates the recurrent mass
lesion on the pineal gland re-
gion, filling the fourth ventricle
anteriorly and the superior cer-
ebellar cistern posteriorly. Cere-
bellar tonsils are herniated
10 mm through foramen
magnum
Fig. 5 a Pleomorphic tumor
cells with round and spindle
morphology, mixed with larger
cells with cytoplasm and loose
myxoid stroma (H & E, ×200).
b Cytoplasmic desmin immu-
noreactivity within the tumor
cells (streptavidin–biotin, ×400)
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history of cancer, a genetic susceptibility could have been a
causative factor in the development of two different tumors.
The p53 tumor suppressor gene, located on the short arm
of human chromosome 17, encodes a 53-kDa phosphopro-
tein that functions as a regulator of cell proliferation and
apoptosis. Alterations of the p53 gene or its encoded protein
are the most common genetic abnormalities observed in
human cancers, having been associated with virtually every
sporadically occurring malignancy [13]. Even if the family
history was negative for any other cancer consistent with the
Li–Fraumeni Syndrome (LFS), germ line p53mutation must
be kept in mind in children with multiple primary tumors
[15]. Majority of the patients with rhabdomyosarcoma are
genetically susceptible to tumor development. Rhabdomy-
osarcoma is themost common sarcoma described in LFS and
is associated with a carrier state of a constitutionally altered
allele of the p53 tumor suppressor gene [13–15]. Diller et al.
[13] reported that the presence of p53 mutation might pre-
dispose children to the development of rhabdomyosarcoma
at an early age. Children with astrocytoma and oligoas-
trocytoma most commonly have inherited p53 gene muta-
tions. In contrast, p53 gene mutation has been rare in the
tumorigenesis of pineoblastoma [16, 17].
Concurrent combination of pineoblastoma and rhabdo-
myosarcoma has not been reported before. The presented
case has no family history of cancer and has no detectable
mutation for p53 tumor suppressor gene carried as germ
line. We suggest that concurrence of these tumors could be
due to mutations in other tumor suppressor genes or to
exposure of unknown in utero factors.
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